Literature DB >> 12406945

Prevalence of infection with carcinogenic human papillomavirus among older women.

John W Sellors, Tina L Karwalajtys, Janusz A Kaczorowski, James B Mahony, Alice Lytwyn, Sylvia Chong, Joanna Sparrow, Attila Lorincz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12406945      PMCID： PMC128399     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Human papillomavirus and cancer: the epidemiological evidence.

Authors:  N Muñoz
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

2.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.

Authors:  N F Schlecht; S Kulaga; J Robitaille; S Ferreira; M Santos; R A Miyamura; E Duarte-Franco; T E Rohan; A Ferenczy; L L Villa; E L Franco
Journal:  JAMA       Date:  2001-12-26       Impact factor: 56.272

3.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

4.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.

Authors:  R Herrero; M H Schiffman; C Bratti; A Hildesheim; I Balmaceda; M E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; J Morales; M Hutchinson; L Mango; M Alfaro; N W Potischman; S Wacholder; C Swanson; L A Brinton
Journal:  Rev Panam Salud Publica       Date:  1997-05

5.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

6.  Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.

Authors:  J W Sellors; J B Mahony; J Kaczorowski; A Lytwyn; H Bangura; S Chong; A Lorincz; D M Dalby; V Janjusevic; J L Keller
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

8.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396
  8 in total
  10 in total

Review 1.  Clinical significance of human papilloma virus infection in the cervical lesions.

Authors:  Shuang Li; Yu-Han Meng; Hu Ting; Jian Shen; Ding Ma
Journal:  Front Med China       Date:  2010-07-16

Review 2.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

3.  Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Hui-Wen Wilkerson; Federico M Farin; Joseph J Carter; Denise A Galloway; Janet R Daling; Effie W Petersdorf; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

4.  Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women.

Authors:  C González; J Canals; M Ortiz; L Muñoz; M Torres; A García-Saiz; J Del Amo
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

5.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

Review 6.  Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis.

Authors:  Andrea C Tricco; Carmen H Ng; Vladimir Gilca; Andrea Anonychuk; Ba' Pham; Shirra Berliner
Journal:  BMC Infect Dis       Date:  2011-09-05       Impact factor: 3.090

7.  Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.

Authors:  Shalini L Kulasingam; Raghu Rajan; Yvan St Pierre; C Victoria Atwood; Evan R Myers; Eduardo L Franco
Journal:  BMC Med       Date:  2009-11-09       Impact factor: 8.775

8.  Model for assessing human papillomavirus vaccination strategies.

Authors:  Elamin H Elbasha; Erik J Dasbach; Ralph P Insinga
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors:  Richard A Moore; Gina Ogilvie; Daniel Fornika; Veronika Moravan; Marc Brisson; Mahsa Amirabbasi-Beik; Anita Kollar; Thomas Burgess; Ray Hsu; Laura Towers; Jane Lo; Jasenka Matisic; Angela Brooks-Wilson
Journal:  Cancer Causes Control       Date:  2009-05-29       Impact factor: 2.506

10.  Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Jesse Ortendahl; Karen M Kuntz; Sue J Goldie; Joshua A Salomon
Journal:  Popul Health Metr       Date:  2007-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.